Description
Description
Mastoral
Specification
Common | |
Active substance | Methyl Drostanolone |
Indications | Mastoral is indicated for treatment of breast cancer in elderly post-menopausal as part of aspecific immunotherapy. |
Dosage | |
Quantity | |
Unit | |
Time | |
Potency | |
Quantity | 10 |
Unit | Milligram |
Packaging | |
Quantity | 50 |
Unit | Tablet |
Type | Carton |
Presentation | Each carton contains 50 tablets of 10mg each |